Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient

Pasquale Capaccio, Francesco Ottaviani, Valeria Cuccarini, Mario Corbellino, Carlo Parravicini, Stefano Menzo, Antonio Schindler, Lorenzo Pignataro

Research output: Contribution to journalArticlepeer-review


Intranasal schneiderian exophytic squamous papillomatosis is rare and often secondary to human papilloma virus infection. Treatment usually consists of repeated surgical or endoscopic excisions due to recurrences. The use of intravenous or intralesional or topically applied cidofovir, a cytidine nucleotide analogue suppressing viral replication, alone or as adjuvant therapy has been proposed and described in the literature for the treatment of other human papillomavirus (HPV)-related lesions. We firstly describe a successful combined approach of surgery and topical cidofovir for recurrent nasal HPV-related exophytic squamous papillomatosis in a HIV-infected patient. As no untoward effects were encountered this therapeutical option should be considered in the management of recurrent nasal papillomatosis in HIV-infected patients.

Original languageEnglish
Pages (from-to)937-939
Number of pages3
JournalEuropean Archives of Oto-Rhino-Laryngology
Issue number6
Publication statusPublished - Jun 2009


  • Cidofovir
  • Hepatitis C
  • HIV
  • HPV
  • Nasal papilloma
  • Papillomatosis

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient'. Together they form a unique fingerprint.

Cite this